[Competitive enzyme mechanisms in the therapy of hemoblastosis using antimetabolites].
D000328:Adult; D000493:Allopurinol / Q000494:pharmacology; D000581:Amidohydrolases / Q000037:antagonists & inhibitors; D000963:Antimetabolites / Q000494:pharmacology* / Q000627:therapeutic use; D003561:Cytarabine / Q000494:pharmacology; D004791:Enzyme Inhibitors; D005260:Female; D005472:Fluorouracil / Q000494:pharmacology; D005493:Folic Acid Antagonists / Q000494:pharmacology; D006801:Humans; D007938:Leukemia / Q000188:drug therapy* / Q000201:enzymology; D008025:Ligases / Q000037:antagonists & inhibitors; D008297:Male; D015122:Mercaptopurine / Q000494:pharmacology; D008875:Middle Aged; D013937:Thymidine Kinase / Q000037:antagonists & inhibitors; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors
D000963:Antimetabolites; D004791:Enzyme Inhibitors; D005493:Folic Acid Antagonists; D003561:Cytarabine; D000493:Allopurinol; D015122:Mercaptopurine; D014969:Xanthine Oxidase; D013937:Thymidine Kinase; D000581:Amidohydrolases; D008025:Ligases; D005472:Fluorouracil
Kompetitive Enzymmechanismen bei der Therapie von Hämoblastosen mit Antimetaboliten.